Methods and materials for the treatment of testosterone deficiency in men

Details for Australian Patent Application No. 2002318225 (hide)

Owner Repros Therapeutics Inc.

Inventors Podolski, Joseph S.

Agent Spruson & Ferguson

Pub. Number AU-B-2002318225

PCT Number PCT/US02/21524

PCT Pub. Number WO2003/005954

Priority 60/304,313 09.07.01 US

Filing date 9 July 2002

Wipo publication date 29 January 2003

Acceptance publication date 13 December 2007

International Classifications

A61K 31/225 (2006.01)

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 60/304,313 09.07.01 US

22 May 2003 Application Open to Public Inspection

  Published as AU-B-2002318225

28 June 2007 Change of Name(s) of Applicant(s), Section 104

  Zonangen, Inc. The name of the applicant has been changed to Repros Therapeutics Inc.

13 December 2007 Application Accepted

  Published as AU-B-2002318225

10 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002318226-FUNCTIONAL FLUORINE-CONTAINING POLYMERS AND IONOMERS DERIVED THEREFROM

2002318224-RECOVERY AND PURIFICATION OF 3,4-EPOXY-1-BUTENE USING HIGHBOILING SOLVENTS